Researchers are looking into how mesenchymal stem cells (MSCs) and exosomes might help people with allergic rhinitis. These components are known to have anti-inflammatory effects and can help repair barriers in the body. They work through paracrine pathways, which means they send signals to help the body heal itself.
While these treatments show promise, most of the current evidence comes from animal models rather than human clinical trials. Additionally, natural stem cells can be difficult to keep in the right place in the body for a long time. However, new delivery systems and modified cells are being developed to improve how well these treatments work.
It is important to note that there is currently a lack of large-scale, long-term human data. There is also a need for more standardized products before these treatments can be widely used. For now, these findings represent a potential new way to manage allergies without using hormones, but more research is needed to confirm their safety and effectiveness in people.
